tadalafil has been researched along with sulindac sulfide in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (sulindac sulfide) | Trials (sulindac sulfide) | Recent Studies (post-2010) (sulindac sulfide) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 212 | 2 | 67 |
| Protein | Taxonomy | tadalafil (IC50) | sulindac sulfide (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 2 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.05 | |
| Adenosine receptor A3 | Homo sapiens (human) | 7.231 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.231 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.4015 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.092 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.9182 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.231 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abadi, AH; Chang, WC; Chen, X; Clapper, ML; Gary, BD; Grizzle, WE; Gurpinar, E; Keeton, AB; Li, N; Li, Y; Moyer, MP; Piazza, GA; Tinsley, HN; Xi, Y; Zhu, B | 1 |
1 other study(ies) available for tadalafil and sulindac sulfide
| Article | Year |
|---|---|
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Topics: Antineoplastic Agents; Apoptosis; Caco-2 Cells; Carbolines; Cell Line; Cell Proliferation; Colonic Neoplasms; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclin D1; HCT116 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Sulindac; Survivin; Tadalafil; Wnt Signaling Pathway | 2013 |